Product image of Eribulin Medac (Eribulin) supplied by GNH India

Eribulin Medac

Active Ingredient:
Eribulin
Origin:
EU

Eribulin Medac (Eribulin)

Eribulin Medac is a medication used in cancer treatment. This intravenous drug is designed to target and disrupt cancer cell division, offering a therapeutic option for certain advanced malignancies.

Manufacturer / TM Owner

Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Eribulin Medac is primarily used in the treatment of metastatic breast cancer and other advanced malignancies. It works by interfering with the cell division process, which can help slow the progression of cancer. Patients often wonder, 'What is Eribulin used for?' This medication is typically considered when other treatments have proven ineffective.

Side Effects

  • Common effects of Eribulin Medac may include fatigue, nausea, and peripheral neuropathy. Some patients also experience hair loss and a decrease in white blood cell counts. These effects can vary widely among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

  • Eribulin Medac should be handled with care, as it is intended for intravenous use only. It is important to follow the guidance of a healthcare professional when administering this medication. Patients should be monitored regularly for any adverse reactions or changes in their condition.

Avoid Interactions

  • Eribulin Medac may interact with other medications, particularly those that affect the liver or bone marrow. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of Eribulin Medac.

Frequently Asked Questions

Eribulin is used in the treatment of metastatic breast cancer and other advanced malignancies. It is typically considered when other treatments have proven ineffective.

Eribulin is administered intravenously, meaning it is delivered directly into the bloodstream through a vein.

Common side effects of Eribulin may include fatigue, nausea, peripheral neuropathy, hair loss, and a decrease in white blood cell counts.

Eribulin may interact with other medications, particularly those that affect the liver or bone marrow. It is important to consult a healthcare provider before combining Eribulin with other treatments.

Eribulin should be handled with care and administered only by a healthcare professional. Regular monitoring for adverse reactions is recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Eribulin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT